UK markets closed

Mustang Bio, Inc. (2W60.F)

Frankfurt - Frankfurt Delayed price. Currency in USD
Add to watchlist
0.0000-4.8400 (-100.00%)
At close: 08:24AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
30,844
41,040
63,949
55,706
47,301
-
Selling general and administrative
8,792
9,686
12,210
11,017
9,505
-
Total operating expenses
39,636
50,726
76,159
66,723
56,806
-
Operating income or loss
-39,636
-50,726
-76,159
-66,723
-56,806
-
Interest expense
139
1,314
3,359
15
3,917
-
Total other income/expenses net
-
-412
1,304
-
-
-
Income before tax
-40,100
-51,602
-77,525
-66,370
-60,015
-
Income from continuing operations
-40,100
-51,602
-77,525
-66,370
-60,015
-
Net income
-40,100
-51,602
-77,525
-66,370
-60,015
-
Net income available to common shareholders
-40,100
-51,602
-77,525
-66,370
-60,015
-
Basic EPS
-8.93
-
-11.25
-11.40
-17.10
-19.35
Diluted EPS
-8.93
-
-11.25
-11.40
-17.10
-19.35
Basic average shares
7,288
-
6,896
5,859
3,506
2,404
Diluted average shares
7,288
-
6,896
5,859
3,506
2,404